Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 5,772 shares at $154.54 ($896K) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Open-market sale of $896k ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.54 | 1,259 | $195K | 21.7% |
| 2 | $154.54 | 1,259 | $195K | 21.7% |
| 3 | $155.45 | 993 | $154K | 17.2% |
| 4 | $155.45 | 993 | $154K | 17.2% |
| 5 | $156.38 | 588 | $92K | 10.3% |
| 6 | $156.38 | 588 |
| $92K |
| 10.3% |
| 7 | $157.30 | 84 | $13K | 1.5% |
| 8 | $158.09 | 8 | $1K | 0.1% |
| Total | $155.27 avg | 5,772 | $896K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |